Drug Neuroscience

Belsomra

Payments companies reported to CMS as associated with Belsomra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$560Kassociated payments (2023-2025)
14,512clinicians with associated payments
1company reporting

By year

2023 $560K
2024 $10.87

Payments reported as associated with Belsomra, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Family Medicine $142K
Internal Medicine $109K
Family $93K
Physician Assistant $48K
Nurse Practitioner $22K
Psychiatry $20K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Belsomra

These are the largest totals companies reported as associated with Belsomra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Prashant Gajwani Houston, TX Psychiatry $2,752.82
Thomas Scammell Boston, MA Neurology (Psychiatry & Neurology) $1,750.00
Alon Avidan Los Angeles, CA Neurology (Psychiatry & Neurology) $960.00
Marylou Romo-Gritzewsky Freedom, CA Internal Medicine $307.31
Ric Garrison Palmdale, CA Family Medicine $272.67
Kay Roberts Palmdale, CA Medical $258.26
Siva Arunasalam Victorville, CA Cardiovascular Disease $247.98
Ronnie Claiborne Bakersfield, CA General Practice $245.34
Greg Baker Bakersfield, CA Physician Assistant $245.34
Sarah Robertson Palmdale, CA Family $244.70

Prescribed Belsomra?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.